- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03546010
Oculometry as an Attentional Mechanism Evaluation Tool and Attention Deficit Hyperactivity Inhibition (TDAH)
The aim of this study is to analyse thanks to eye tracking experiments ocular movement classical parameters in children with attention deficit hyperactivity (ADH) and to compare them to results obtained in healthy children and to results obtained with neuropsychological tests commonly used in standard health care.
We should then be able to compare eye tracking with neuropsychological parameters.
The final objective is to give to health professional a tool for ADH investigation with which they should be able to do a simple and effective follow up of children with ADH.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Annie Laurent, MD
- Phone Number: 04 76 76 54 19
- Email: AnnieLaurent@chu-grenoble.fr
Study Contact Backup
- Name: Nathalie Guyader, MCD UJF
- Phone Number: 04 76 57 43 72
- Email: nathalie.guyader@gipsa-lab.grenoble-inp.fr
Study Locations
-
-
-
Grenoble, France
- Recruiting
- Grenoble Alps Hospital
-
Contact:
- Annie Laurent, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Children between 8 and 12 years old
- Boys and girls
- DSM-IV-TR diagnostic criteria for ADH
- Children with methylprednisone treatment
- Social security affiliation
- signed informed consent
Exclusion Criteria:
- specialised scholarship
- refusal from children or parents
- too law results in WISC test (pre-inclusion test)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Oculometric and neuropsychological tests
Oculometric tests and neuropsychological tests
|
WISC test, BRIEF test, NEPSY-2 test, TAP2.3 test, Teach test
When the subject see a peripheric target, he should take a look not at the target but in the controlateral half-field, at a mirror position.
This is called an anti-saccade task.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Correlation between oculometric and neuropsychological tests in ADH evaluation
Time Frame: Day 1
|
Differentiation between simple oculomotor disorder and attentional-visual disorder
|
Day 1
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Annie Laurent, MD, Grenoble Alps University Hospital
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 38RC14.100
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Attention Deficit-Hyperactivity
-
Cingulate TherapeuticsRecruitingPhase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301ADHD | Attention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
Ornit CohenUnknownAttention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | Attention Deficit Disorder | Attention Deficit Disorders With Hyperactivity | Attention Deficit Hyperactivity DisordersIsrael
-
Cingulate TherapeuticsPremier Research Group plcActive, not recruitingADHD | Attention Deficit Hyperactivity Disorder | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
New River PharmaceuticalsShireCompletedAttention Deficit Hyperactivity Disorder | Attention Deficit Disorders With Hyperactivity | Attention Deficit Hyperactivity DisordersUnited States
-
New River PharmaceuticalsCompletedAttention Deficit Hyperactivity Disorder | Attention Deficit Disorders With Hyperactivity | Attention Deficit Hyperactivity DisordersUnited States
-
Corium, Inc.Worldwide Clinical Trials; Premier Research Group plc; Almac; Prometrika, LLCRecruitingAttention Deficit/Hyperactivity DisorderUnited States
-
Corium, Inc.Premier Research Group plc; Almac; Prometrika, LLCRecruitingAttention Deficit/Hyperactivity DisorderUnited States
-
Massachusetts General HospitalShire Human Genetic Therapies, Inc.Active, not recruitingAttention Deficit/Hyperactivity DisorderUnited States
-
Ataturk UniversityCompletedAttention-deficit/Hyperactivity DisorderTurkey
-
Massachusetts General HospitalShireActive, not recruitingAttention Deficit/Hyperactivity DisorderUnited States
Clinical Trials on Neuropsychological tests
-
Istituto Auxologico ItalianoRecruiting
-
Hospices Civils de LyonCompleted
-
Association pour le Développement et l'Organisation...Association Française du Syndrome d'Ondine; Fonds de Recherche en Santé RespiratoireCompletedHealthy | Amyotrophic Lateral Sclerosis | Ondine SyndromeFrance
-
South Tees Hospitals NHS Foundation TrustUnknown
-
University Medical Center GroningenNot yet recruitingCognitive Dysfunction | Glioma, Malignant
-
University Hospital, Clermont-FerrandRecruiting
-
Rennes University HospitalRecruitingNeurological Diseases | Central Nervous SystemFrance
-
University Hospital, BordeauxCompletedAttention-Deficit/Hyperactivity DisorderFrance
-
University Hospital, CaenUnknown
-
Mid and South Essex NHS Foundation TrustAnglia Ruskin UniversityCompleted